Zydus Hydrocortisone Sodium Succinate for Injection
Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.
Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.
Tretinoin Cream USP, 0.05% failed impurities and degradation specifications.
3 productsLidocaine Ointment USP, 5% failed content uniformity specifications.
Fosfomycin Tromethamine Granules for Oral Solution failed impurities and degradation specifications.
Biospectra Tris/Tromethamine failed stability specifications.
Apheresis Platelets, PAS, Leukocytes Reduced were not tested for pH or platelet yield.
Orbi 20 Whitening Cream is contaminated with mercury.
2 productsParoxetine Extended-Release Tablets failed dissolution specifications.
Ranolazine Extended-Release Tablets fail dissolution specifications.
Olanzapine Tablets, USP 5 mg, failed impurities and degradation specifications.
Apheresis Platelets were distributed without testing for pH or platelet yield.
Chlorthalidone Tablets failed dissolution specifications.
Phytonadione Injectable Emulsion failed impurities and degradation specifications.
Fluphenazine HCl Elixir failed stability specifications.
12 productsGlutathione, Myer's Cocktail, and Tri-Immune Boost injectable vials may contain elevated endotoxin levels, which could cause significant medical events.
3 productsLidocaine Ointment USP, 5%, Speermint Flavor failed content uniformity specifications and assay specifications.
Fluphenazine Hydrochloride Tablets failed impurity specifications during stability testing.
An Out of Specification result (OOS) related to bacterial endotoxin testing in a single lot of catheters.
3 productsTrokendi XR extended-release capsules failed dissolution specifications.
Mycophenolate Mofetil for injection fails dissolution specifications.
Pooled Cryoprecipitated AHF was not prepared in accordance with specifications.
Revcovi injection failed stability specifications for protein concentration profile.
Prasugrel Tablets, USP, 10mg failed dissolution specifications and stability testing.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were not tested for pH and were distributed.
Paxil CR tablets failed dissolution specifications and stability testing acceptance criteria.
Ramipril Capsules USP, 10 mg, failed impurity specifications.
Clobetasol Propionate Cream USP, 0.05%, 60 g tube failed content uniformity specifications.
American Contract System Convenience Kits did not meet applicable performance specifications.
4 productsMedline medical convenience kits contain neurosponges with potential out-of-specification endotoxin levels.
4 productsGlutathione 200 mg/mL sterile multidose vials have elevated bacterial endotoxin levels, which could cause significant medical events.
Acamprosate Calcium, Delayed-Release Tablets failed dissolution specifications.
Diovan (valsartan) 160 mg tablets failed dissolution specifications.
Neisseria meningitidis Gp C 2ml/VL is not performing to IFU criteria, not positive to ATCC13102 within 60 seconds.
Mirabegron Extended-Release Tablets contain an impurity above specification.
Compounded glutathione vials have elevated bacterial endotoxin levels, which could cause fever, hypotension, inflammatory reactions, anaphylactic shock.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were distributed without platelet yield testing.
The 5-Plasma Bivalirudin AMR Verification Kit has stability issues that degrade measurable bivalirudin.
3 productsSyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls have out-of-specification sodium azide concentration, causing low health risk.
The Syva Emit Disopyramide Assay has an out-of-specification sodium azide concentration, which can cause mild skin or eye irritation.
The Power Over Fiber Base Module is not certified and is improperly labeled.
Proin ER tablets failed dissolution specifications, which can affect drug release.
Dabigatran Etexilate Capsules failed impurity and degradation specifications.
4 productsGlycopyrrolate Oral Solution failed impurities and degradation specifications due to an unidentified impurity.
3 productsAmlodipine and Olmesartan Medoxomil Tablets failed dissolution specifications, with Olmesartan Medoxomil content below specifications.
Trokendi XR, topiramate extended-release capsules failed dissolution specifications.
3 productsDabigatran etexilate capsules failed impurity and degradation specifications during stability testing.
2 productsApheresis Platelets, Leukocytes Reduced, Irradiated did not meet platelet yield specifications.
The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System was exposed to an out-of-specification sterilization dose.